Articles Archives - Page 673 of 698

ThursdayJun 14, 2018 1:34 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Appeals to Investors with Slow Burn Rate, Model that Goes Beyond Cannabis Sector

Chris Bunka, CEO of LXRP, in an interview with CFN Media Group, stated that his company’s cash flow is strengthening from licensing and R&D, with technology applicable to other sectors Bunka noted that LXRP’s 71 million share count is kept purposely low relative to others in the category, with its valuation growing by “close to 2,000 percent” over the past several years LXRP’s goal is to slow disease and make cannabis acceptable to the general population Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent CFN Media Group interview that his company has gained in…

ThursdayJun 14, 2018 12:22 pm

ChineseInvestors.com, Inc. (CIIX) Expects to Reach Chinese-Speaking Audience of More Than 500,000 with Bitcoin Talk Show

CIIX’s strategy is to blanket Chinese-speaking population in America with daily cryptocurrency broadcast from NYSE, podcast, online site, ATMs, mining operation and educational courses Bitcoin and blockchain show is on Phoenix North America Chinese Channel and will also be broadcast online at NewCoins168.com, CIIX’s website, and its YouTube channel CIIX has established a cryptocurrency mining operation and signed an LOI to acquire the assets of XBTeller.com for some $2.5 million; that company has nine Bitcoin ATMs in Colorado ChineseInvestors.com, Inc. (OTCQB: CIIX) is launching a new 22-minute monthly TV program titled ‘Bitcoin Talk Show’, which it expects will reach more…

ThursdayJun 14, 2018 11:42 am

AnalytixInsight, Inc. (TSX.V: ALY) (OTCQB: ATIXF) Continues to Build Big Data Successes through Strategic Partnerships

AnalytixInsight’s first-quarter report notes 200 percent jump in year-over-year revenues Market analysts foresee big data industry reaching $84 billion level by 2024 Company’s partners include European bank Intesa Sanpaolo, multi-national media giant Thomson Reuters Building on a year of growth that led to its designation as “one of the top 10 performing technology companies in the 2018 Venture 50” with a market cap change of 288 percent on the Canadian TSX exchange (http://ibn.fm/fdPkl), artificial intelligence data delivery company AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is off to a strong start for 2018 with a 200 percent-plus increase in revenue year-over-year, as…

ThursdayJun 14, 2018 10:50 am

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is “One to Watch”

Focused on California, the largest legal cannabis market in North America Operates an attractive royalty model that is beneficial for operators and the company Established partnerships with best-in-class operating entities Extensive network provides access to top-tier projects and operators Executive leadership team with 40+ years of combined experience in fund raising, capital management, corporate development, merchant and commercial banking FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages…

WednesdayJun 13, 2018 12:43 pm

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) Brings the Passion of the Games Home to Fans

Social media app that harnesses enthusiasm for sports Novel marketing campaign with hashtag #WearYourColors Investment banking executive joins as financial advisor FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) is doing for sports fans today what the Circus Maximus did for ancient Romans. At this largest of Roman hippodromes (horse racing tracks), some 2,000 feet long and 600 feet wide, spectators were treated to captivating contests that typically featured 12 four-horse chariots racing for four miles as they traversed the Circus’ circumference seven times. The passion and excitement of 250,000 fans, the hippodrome’s seating capacity, as they cheered…

WednesdayJun 13, 2018 12:32 pm

American-Swiss Capital, Inc. an Early Investor in a Growing Economy

Discovers undervalued real estate investments with the potential for high rate of return Economic potential for Montenegro as it partners with NATO and seeks to join the EU Investment in two beachside developments in Tivat, Montenegro American-Swiss Capital, Inc., headquartered in Miami, Florida, is a company focused on seeking quality and undervalued real estate investments to create a high rate of return. The company’s experienced management team possesses the knowledge and skills required to consistently provide accurate and reliable research specifically designed to identify the safest and most profitable investment opportunities. American-Swiss Capital is positioned as a conduit between U.S.…

WednesdayJun 13, 2018 12:06 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on Delivery of Bioactive Substances via Oral Ingestion

Lexaria has its patented DehydraTECH™ nutrient infusion technology This technology has patent protection for cannabidiol and all other non-psychoactive cannabinoids DehydraTECH™ technology provides greater bio-absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a worldwide leader in enhancing the gastro-intestinal delivery of edible cannabinoid products. The company has its patented nutrient infusion technology called DehydraTECH™. This technology significantly improves the body’s ability to absorb cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine, drugs, supplements and other beneficial molecules. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has patents granted in the United States and Australia for applications of its…

WednesdayJun 13, 2018 11:25 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Extends Share Warrants Expiry amid Growing Alternative Medicine Popularity

PreveCeutical moves on recent stock split to boost share appeal Company’s organic therapeutics aim to relieve maladies for patients with diabetes, brain injuries and other conditions Alternative medicines market expected to generate nearly $200 billion in revenues by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) continues working to shore up its share appeal while seeking remedies for a variety of physical ailments through its nature-centric research to help patients with type 2 diabetes and obesity, mild traumatic brain injury, cancer and pervasive pain. PreveCeutical Medical completed a forward stock split last month on the basis of five…

WednesdayJun 13, 2018 11:03 am

Pressure BioSciences, Inc. (PBIO) Announces $7.24M Debt-to-Equity Swap as it Prepares for 2018 Uplisting to National Stock Exchange

Equity swap further boosts Pressure BioSciences’ plans to uplist to a major stock exchange later this year Latest deal brings total debt-to-equity conversions to over $13.6M in past 30 days 2015/2016 debentures, line-of-credit and promissory note, plus various short-term debt, now converted to equity Company’s recently acquired Pre-EMT™ platform, allowing for improved protein-based drug development, has significant market potential and adds to a string of technological developments Pressure BioSciences Inc.’s (OTCQB: PBIO) ambitions to achieve listing on a major stock exchange this year have taken another major step forward as yet another group of debt holders have agreed to a…

Site Search

Company Search

Category: Articles